Clear Search sequence regions


  • aspirin (12)
  • asthma (2)
  • diagnosis (1)
  • humans (1)
  • leukotrienes (3)
  • nasal polyps (1)
  • patients (3)
  • sinus (1)
  • triad (1)
  • Sizes of these terms reflect their relevance to your search.

    Aspirin-exacerbated respiratory disease (AERD) is characterized by the triad of asthma, sinonasal polyposis, and aspirin intolerance. The hallmark of the disease is baseline overproduction of cysteinyl leukotrienes via the 5-lipoxygenase pathway, exacerbated by ingestion of aspirin. Patients with AERD have high rates of recidivistic polyposis following sinus surgery, although the improvement in quality of life following surgery is similar to aspirin-tolerant patients. The diagnosis is secured by a positive aspirin provocation test, usually administered by a medical allergist. Aspirin therapy is a unique treatment consideration for patients with AERD. Copyright © 2016 Elsevier Inc. All rights reserved.

    Citation

    Evan S Walgama, Peter H Hwang. Aspirin-Exacerbated Respiratory Disease. Otolaryngologic clinics of North America. 2017 Feb;50(1):83-94

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27888917

    View Full Text